Clinicopathologic and Molecular Characterization of Inflammatory Bowel Disease–Associated Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms
Modern Pathology · 2024
DOI: 10.1016/j.modpat.2024.100566 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2024. Verfasst von Xiaoyan Liao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Rochester Medical Center, Rochester, New York. Electronic address: xiaoyan_liao@urmc.rochester.edu. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: University of Rochester Medical Center.
Abstract (Originalsprache)
The pathogenesis of neuroendocrine carcinomas (NECs) and mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) in the gastrointestinal tract remains poorly understood. This study aims to characterize the clinicopathologic and molecular features of NEC/MiNEN in patients with inflammatory bowel disease (IBD). Eighteen surgically resected IBD-associated intestinal carcinomas with a minimum of 30% neuroendocrine component were collected from 6 academic centers and compared with a control group of 12 IBD-associated carcinomas lacking neuroendocrine differentiation. Both groups exhibited a male predominance and similar age distribution. The NEC/MiNEN group was more likely to have a higher percentage of Crohn disease (9/18 vs 1/12; P = .024), occur in the rectum (9/18 vs 3/12) and small intestine (4/18 vs 0/12) (P < .01), be diagnosed on resection without a preceding biopsy (6/18 vs 0/12; P = .057), and have unidentifiable precursor lesions (10/18 vs 1/12; P = .018) than the control group. Synchronous carcinoma, advanced tumor stage (pT3 and pT4), and lymph node metastasis occurred at similar rates; however, the NEC/MiNEN group had a higher incidence of angiovascular invasion (14/18 vs 4/12; P = .024), distant metastasis (8/18 vs 1/12; P = .049), mortality (8/18 vs 2/12; P = .058), and worse survival (Kaplan-Meier; P = .023) than the control group. All tested cases were mismatch repair proficient. A Ki-67 proliferation index ranged from 25% to 100%. Next-generation sequencing in 11 NEC/MiNEN cases revealed low tumor mutational burdens but complex genetic abnormalities commonly involving TP53 (9/11; 82%), FBXW7 (4/11; 36%), and APC (3/11; 27%) genes, with the other genetic alterations randomly occurring in 1 or 2 cases. The neuroendocrine component, which shared similar molecular alterations as the nonneuroendocrine component, was subcategorized into intermediate (G3a) and high grade (G3b); the higher grade correlated with more genetic alterations. In conclusion, IBD-associated NEC/MiNEN shows diverse histologic features, variable precursor lesions, intricate genetic abnormalities, and aggressive biologic behavior. The classification and grading of gastrointestinal NEC/MiNEN may be refined for better clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Rochester Medical Center, Rochester, New York. Electronic address: xiaoyan_liao@urmc.rochester.edu.
- Department of Pathology, University of Rochester Medical Center, Rochester, New York.
- Department of Pathology, Indiana University, Indianapolis, Indiana.
- Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York.
- Department of Pathology, Columbia University, New York, New York.
- Department of Pathology, University of California San Francisco, San Francisco, California.
Förderung
- University of Rochester Medical Center
Zitieren
APA
Liao, X., Schmidt, A. L., Zhang, D., Li, P., Wang, X., Ko, H. M., Choi, W. T., Alpert, L., Hao, Y., Kovar-Peltz, S., Polydorides, A. D., Wanjari, P., Mastro, J., & Wang, P. (2024). Clinicopathologic and Molecular Characterization of Inflammatory Bowel Disease–Associated Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms. Modern Pathology. https://doi.org/10.1016/j.modpat.2024.100566
Vancouver
Liao X, Schmidt AL, Zhang D, Li P, Wang X, Ko HM, et al. Clinicopathologic and Molecular Characterization of Inflammatory Bowel Disease–Associated Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms. Modern Pathology. 2024. doi:10.1016/j.modpat.2024.100566
BibTeX
@article{Liao2024,
author = {Liao, Xiaoyan and Schmidt, Alicia L and Zhang, Dongwei and Li, Peizi and Wang, Xintong and Ko, Huaibin M and Choi, Won-Tak and Alpert, Lindsay and Hao, Yansheng and Kovar-Peltz, Sierra and Polydorides, Alexandros D and Wanjari, Pankhuri and Mastro, Julius and Wang, Peng},
title = {Clinicopathologic and Molecular Characterization of Inflammatory Bowel Disease–Associated Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms},
journal = {Modern Pathology},
year = {2024},
doi = {10.1016/j.modpat.2024.100566}
}
EUVIMED